Rapid Dose Therapeutics Corp (TSE:DOSE) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Rapid Dose Therapeutics Corp has secured an additional Mitacs Accelerate grant to advance their QuickStrip™ Oral Thin Film technology for vaccine delivery, eliminating the need for intramuscular injections and cold-chain storage. The ongoing research partnership with McMaster University, supported by a total of $85,000 in grants, is set to revolutionize vaccination methods by enabling buccal or sublingual administration. CEO Mark Upsdell highlights the potential for QuickStrip™ to address healthcare delivery and environmental challenges, particularly in regions where traditional vaccine logistics are problematic.
For further insights into TSE:DOSE stock, check out TipRanks’ Stock Analysis page.